The emerging immunosuppressive landscape in the subacute and chronic phases of stroke—marked by an expansion of Tregs, MDSCs, and increased TGF-β and IL-10 production—mirrors the immune evasion mechanisms seen in metastatic progression (53). This evidence concerns the gene IL10 and stroke disorder.